Category: Uncategorized

Categories
Base Metals Emx Royalty Energy Junior Mining Project Generators Uncategorized

EMX Receives Scheduled US$2.25 Million Payment for the Berenguela Silver-Copper Project in Peru

Vancouver, British Columbia–(Newsfile Corp. – November 29, 2021) – EMX Royalty Corporation (NYSE American: EMX) (TSXV: EMX) (FSE: 6E9) (the “Company“, or “EMX“) is pleased to announce receipt of a US $2.25 million payment for the Berenguela silver-copper project (“Berenguela” or the “Project”) in Peru from Aftermath Silver Ltd. (TSXV: AAG) (OTCQB: AAGFF) (“Aftermath Silver”). EMX’s interest in Berenguela resulted from the Company’s acquisition of a portfolio of royalty interests and payments from SSR Mining Inc. and certain of its subsidiaries (“SSR Mining”) (see EMX news releases dated July 29, and October 21, 2021).

Aftermath Silver’s payment is per a definitive acquisition agreement, originally executed with SSR Mining, that outlined a series of staged cash payments (initially totaling US$13 million) and other consideration to acquire 100% interest in the Project, and upon commercial production that will pay a sliding-scale net smelter returns (“NSR”) royalty (see Aftermath Silver news releases dated October 1, and November 23, 2020). The payments are scheduled according to anniversaries of the transaction’s closing date of November 23, 2020 (the “Initial Closing Date”). Aftermath Silver’s cash payment and NSR royalty commitments to EMX for the Berenguela Project are outlined below.

  • US$2.25 million cash to be paid on the first anniversary of the Initial Closing Date. This payment has now been received by EMX;
  • US$2.5 million cash to be paid on the second anniversary of the Initial Closing Date (i.e., November 23, 2022);
  • US$3 million cash to be paid on the fourth anniversary of the Initial Closing Date (i.e., November 23, 2024);
  • Completion of a preliminary feasibility study (“PFS”) and filing on SEDAR of a National Instrument 43-101 technical report summarizing the PFS, within 48 months of the Initial Closing Date (i.e., on or before November 23, 2024);
  • US$3.25 million cash to be paid on the sixth anniversary of the Initial Closing Date (i.e., November 23, 2026); and
  • A sliding-scale NSR royalty on all mineral production from the Berenguela Project for the life of mine commencing at the declaration of commercial production, and based on the following:
    • 1% NSR royalty on all mineral production when the silver market price is up to and including US$25 per ounce;
    • 1.25% NSR royalty on all mineral production when the silver market price is over US$25 per ounce and when the copper market price is above US$2 per pound.

EMX’s interest in Berenguela provides a source of immediate cash flow to the Company, as well as upside potential from future NSR royalty payments on silver-copper production from the Project. Berenguela, which is located in the Puno mining region of southern Peru, serves as a good example of the type of cash flowing mineral property asset that EMX is focused on adding to its growing royalty portfolio.

Michael P. Sheehan, CPG, a Qualified Person as defined by National Instrument 43-101 and an employee of the Company, has reviewed, verified, and approved the disclosure of the technical information contained in this news release.

About EMX. EMX is a precious, base and battery metals royalty company. EMX’s investors are provided with discovery, development, and commodity price optionality, while limiting exposure to risks inherent to operating companies. The Company’s common shares are listed on the NYSE American Exchange and TSX Venture Exchange under the symbol “EMX”, as well as on the Frankfurt exchange under the symbol “6E9”. Please see www.EMXroyalty.com for more information.

For further information contact:

David M. Cole
President and Chief Executive Officer
Phone: (303) 973-8585
Dave@EMXroyalty.com

Scott Close
Director of Investor Relations
Phone: (303) 973-8585
SClose@EMXroyalty.com

Isabel Belger
Investor Relations (Europe)
Phone: +49 178 4909039
Ibelger@EMXroyalty.com

Neither the TSX-V nor its Regulation Services Provider (as that term is defined in policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release may contain “forward looking statements” that reflect the Company’s current expectations and This news release may contain “forward looking statements” that reflect the Company’s current expectations and projections about its future results. These forward-looking statements may include statements regarding perceived merit of properties, exploration results and budgets, mineral reserves and resource estimates, work programs, capital expenditures, timelines, strategic plans, market prices for precious and base metal, or other statements that are not statements of fact. When used in this news release, words such as “estimate,” “intend,” “expect,” “anticipate,” “will”, “believe”, “potential”, “upside” and similar expressions are intended to identify forward-looking statements, which, by their very nature, are not guarantees of the Company’s future operational or financial performance, and are subject to risks and uncertainties and other factors that could cause the Company’s actual results, performance, prospects or opportunities to differ materially from those expressed in, or implied by, these forward-looking statements. These risks, uncertainties and factors may include, but are not limited to: unavailability of financing, failure to identify commercially viable mineral reserves, fluctuations in the market valuation for commodities, difficulties in obtaining required approvals for the development of a mineral project, increased regulatory compliance costs, expectations of project funding by joint venture partners and other factors.

Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this news release or as of the date otherwise specifically indicated herein. Due to risks and uncertainties, including the risks and uncertainties identified in this news release, and other risk factors and forward-looking statements listed in the Company’s MD&A for the quarter ended September 30, 2021 (the “MD&A”), and the most recently filed Annual Information Form (the “AIF”) for the year ended December 31, 2020, actual events may differ materially from current expectations. More information about the Company, including the MD&A, the AIF and financial statements of the Company, is available on SEDAR at www.sedar.com and on the SEC’s EDGAR website at www.sec.gov.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/105290

Categories
Uncategorized

What is Covid?

Bob Moriarty
Archives
Nov 23, 2021

Q: What is Covid?
A: Covid is a bad flu. You do not want to catch it.

A giant and perhaps permanent divide exists between the UK and the rest of the world regarding how they view education. In the US and most of the remainder of the world, we focus on answers. We memorize facts. However, in the UK they teach the question is more important than the answer.

Which is correct?

Most people will say, the answer because that is how they have been conditioned to think. But in the UK they will suggest, the question. After all, if you don’t ask the right question, how can you get the right answer?

Since it seems none of the people talking about Covid from any angle have ever actually pondered just what Covid really is. It is easy to understand why so many have come up with the wrong answers again and again.

Q: What is Covid?
A: Covid is a bad flu. You do not want to catch it.

Plant that firmly in your head because you will begin to understand where we are and where we are headed if you just understand what Covid is.

Covid is a bad flu. Once you accept that the answers just naturally flow. The correct answers, not the narrative Fauci, Gates, the Davos monsters, the MSM and the brain dead idiots who seem to occupy almost every government on earth have flogged for almost two years.

Covid is a bad flu.

The ordinary flu can kill and does every year. That’s not the end of the world. We are born, we live and we die. If the flu shortens life for some, it is hardly a big deal. We are all going to die of something in time.

Here’s what appears to be true.

The Wuhan flu appeared in the fall of 2019 around Wuhan China. It looks man made. It probably came from the lab in Wuhan and may have been a planned bio weapon from either China or the US or both. We now know the US was funding gain of function research designed to make more effective bio weapons contrary to sworn testimony from Fauci to Congress. But if Fauci was Pinocchio and his proboscis grew every time he told a lie, he could pole vault to Mars.

Truth is treason in an empire of lies.

The Chinese played their part in their own version of a Kabuki theatre unleashed in late 2019 early 2020 with people dying at their desk, doors on apartments being welded shut and what appeared to be a total lockdown of the city. What went unnoticed by the world was that Beijing wasn’t locked down; the rest of China wasn’t locked down. It was just theatre for the world showing just how deadly this new flu was. Go back to the beginning and the most important question of all.

Q: What is Covid?
A: Covid is a bad flu. You do not want to catch it.

In early 2020 the flu, and that is all that it ever was, came to the US and the rest of the world. Actually now we know that the Wuhan/Covid flu as it was renamed is a disease that mainly affects the obese, blacks, those low in Vitamin D or the elderly. The average age of people that were dying of Covid was actually higher than the average age people die. So it wasn’t the Spanish Flu or Ebola or even measles.

Covid is a bad flu. You don’t want to catch it.

Now we know that judicious use of Vitamin D, Vitamin C and zinc is helpful to avoid the flu in the first place.

Dr. Fauci was good enough to inform the American people that they didn’t need to wear masks. Of course that is true. Just look at anyone actually wearing a mask and ask yourself if you were four hundred times smaller than the holes in the mask, could you make it through? Wearing a mask to prevent the flu is about as effective as installing a roll of barbed wire around your house to keep mosquitos out. And every serious study proved it.

Then he said they did need to wear a mask. Nothing else changed except his professional scientific advice. Masks still don’t work and never have. We know because you can go to any list of those who caught the flu and realize that no one ever actually compared notes between areas with masks and areas without masks. Masks made absolutely no difference in preventing Covid.

Then Fauci in his infinite wisdom and scientific expertise announced that Americans really needed to not only wear a mask, they also needed a face shield. But he is the highest paid Federal government official so people listened to him. Then he said everyone really needed two or more masks. Thenhe said really they only needed one mask. But he forgot to tell us if we still needed the face shield.

Then we were told that to “flatten the curve” by social distancing lockdowns and shutting down the economy would stop the virus in its tracks.

How did that work out? Children have lost the ability to socialize with their playmates, the sales of illegal drugs and alcohol went through the roof. Suicides among teens soared along with murders in adults and spousal abuse, child abuse and alcoholism. If that is how you win a war against a virus that kills less than 0.5% of those infected. And 95% of those infected have little or no signs of any illness. It was called asymptomatic Covid.

It should have been called “No Covid” because the highly vaunted Gold Standard PCR test for Covid didn’t work then and it doesn’t work now. Most of the people told they had Covid never did at all. That’s what having no symptoms means. Even the Nobel Prize winning inventor of the PCR test insisted that it was worthless for determining a disease. He called Fauci a total fraud. Finally after lying to the world for the best part of 18 months even the CDC admits the test is not valid and will not be used after the end of this year. I knew that a year and a half ago.

We have had the ability to prevent Covid and cure it in those who caught it for a year and a half in the form of HCQ and Ivermectin. But Fauci and the Davos crowd are all about profit. There is little profit in HCQ and Ivermectin but there is in another EUA drug named Remdesivir highly touted by the good Dr. Fauci. HCQ is so dangerous that it was available over the counter in France until January 2020, just in time to prevent a bad flu. So the French required a prescription to a drug that has been used safely by millions in Africa. Perhaps Fauci is so senile that he has forgotten being co-author of a clinical study of chloroquine in 2005 where he commented on the remarkable effect it has on eliminating virus.

Fauci certainly doesn’t want anyone remembering that in 2018 Remdesivir was in an Ebola study with three other drugs. Remdesivir proved so deadly that it had to be dropped from the test after killing 53% of those who died during the study. Stick that in your pipe and smoke it. Remdesivir kills between 23% and 40% of those it is administered to for Covid of kidney failure. If you know someone who died of Covid in a hospital in the US during the last 18 months, ask if the specific cause was kidney failure. If so, it wasn’t Covid that killed them it was Remdesivir highly recommended by Fauci.

Even the WHO isn’t that corrupt. The WHO recommends against the use of Remdesivir in hospitalization for Covid because it not only doesn’t work, it is one of the most dangerous drugs known.

Go back to the beginning. Covid is a bad flu. You don’t want to catch it. But the NIH, CDC, WHO fail to talk about how to prevent it and are absurdly head up their asses about how to cure it.

After Donald Trump was defeated in the most corrupt election is US history with thousands of reports of voter fraud and miscounting, the CDC and NIH figured it was time to unleash the final weapon in the battle against a bad flu: an experimental vaccine.

But it wasn’t actually a vaccine just yet. Up until 2015 vaccines were to prevent disease. From 2015 until two months ago a vaccine was to produce immunity to a disease. But the jab, not a vaccine, certainly doesn’t prevent Covid. And the jab, not a vaccine, absolutely doesn’t produce immunity against Covid. So the CDC now says that a vaccine is to provide protection from a specific disease. So the use of soap and water to clean your hands is now a vaccine after September of 2021. How wonderful.

The numbers have been rolling in for months and anyone who does not start to understand a couple of key facts has their head in the sand. Or worse.

The “vaccines” don’t work.

They don’t prevent the disease. They don’t provide immunity to the flu and they have this nasty habit of killing a lot of people who just took the jab. Worse yet those countries with the highest percentage of people who took the jab are also having the highest percentage of people in the hospital and dying of Covid. With friends like Fauci, the CDC and Gates, you don’t need enemies.

That’s the good news. Depending on the multiple number you chose to use, we know there is serious underreporting on the VAERS site, and a reasonable assumption of the number of deaths to Americans from the shot is between 100,000 and 200,000. That’s the good news. The jab has only killed less than 1/10th of one percent of Americans. While the people who were killed by a shot that was supposed to protect them are pretty pissed and their families grieving, they are the lucky ones.

Because the jab is one of those gifts that keeps on giving. It doesn’t prevent illness and death but has the extra advantage of destroying your immune system. Reports are pouring in about star athletes in perfect health keeling over and dying from heart attacks. The criminal companies making the jabs are now pushing the shots onto children. That is a crime against humanity. Children actually are at greater risk of dying from the ordinary flu than from Covid. Actually anyone under 70 years of age is only at a tiny risk of dying from Covid. Basically everything you have been told about Covid and the “vaccine” is a total lie.

Covid is a bad flu. You do not want to catch it.

Enough people have taken the jab that serious numbers are flowing in about the real risk of the shot. In the UK government figures indicate that taking the jab doubles your risk of dying over those who didn’t take the jab. And with time and every extra shot more damage is going to happen to your immune system. All over the world emergency rooms are filling with people with all sorts of maladies related to the destruction of their immune system including heart attacks, strokes, embolism, cancer, and dozens of other life threatening problems.

Throughout the world people are waking up to the transfer of their freedom to the Davos Cartel. In Germany 10,000 doctors and 1,000 lawyers have sued their health officials requiring them to justify the totally illegal rules they are attempting to enforce. Riots are taking place in many countries about the lockdowns that don’t work and the shots that kill either at once or at their leisure but are sure to kill. People are angry but not as angry as they are going to get very soon.

The great die off has begun. The only issue is how many millions or billions will die as a result of criminal behavior on the part of the pharmaceutical companies, lying by governments aided by a “Ministry of Truth” lying mainstream media and those running countries such as Australia and New Zealand far better suited at running concentration camps.

Covid is a bad flu. You do not want to catch it.

As to the masks that didn’t work and the social distancing that didn’t work and the lockdowns that didn’t work and Remdesivir that likes to kill people, the doctors who forgot that once they swore to do no harm, the “vaccines” that aren’t and don’t work, you can believe one of three different things.

Everyone involved from CNN and the media to the medical authorities to heads of governments are dumber than bricks. And though the only problem was a bad flu season and no one was smart enough to ask the right questions, it was just stupidity.

Alternatively you can also believe that the CDC that gets $5 billion in funding yearly from patents on drugs and the guys running the pharmaceutical companies are little more than greedy crooks who are just interested in stealing everything they can. We have a fake pandemic so greedy bastards can make money.

Or you can come to the conclusion that this is all part of a giant wet dream of the Davos 1/10 of 1% who think they can do a far better job of running the world than the rest of humanity and are quite willing to kill off billions in the name of improving the climate for the elite.

Every day it looks more and more like this is all deliberate.

Welcome to The Dark Ages 2.0 where in the future those few who survive will be ruled by warlords and gang leaders. We are in for an interesting winter.

###

Bob Moriarty
President: 321gold
Archives

321gold Ltd

Categories
Capitalism Morality Junior Mining Uncategorized

Where has Honor Gone? Capitalism and Morality 30 July 2022

Irving Resources

Would Black Lives Matter, affirmative action policies, multi-culturalism and the demand for diversity have emerged had the concept of honor still been a part of the backbone of the West? Here are my thoughts:

On Investments

Recently, I had a linked conversation with Cory Fleck and Shad Marquitz about three companies that had not gone up with the general resources market.

Here are some more names with my limit buy-prices:

  • Gran Colombia Warrants (GCM.WT.B; C$3)
  • Silver Dollar (SLV; C$0.66)
  • Baru Gold (BARU; C$0.09)
  • Irving Resources (IRV; C$0.92)
  • Signature Resources (SGU; C$0.065)
  • Maritime Resources (MAE; C$0.13)
  • Aztec Minerals (AZT; C$0.27)
  • Montage Gold (MAU; C$0.65)
  • Newcore Gold (NCAU; C$0.54)
  • Valterra Resources (VQA; C$0.03)

You cannot have liberty in a society where a critical mass of people is not morally conscious. A society lacking moral consciousness will invariably produce goons and tyrants. Your perfect constitution will come to naught in such a society. So, the first step should always be to develop a critical mass of morally conscious people. That is what Capitalism & Morality strives to achieve, which, if our rulers allow, will be held on 30th July 2022.

Categories
Base Metals Emx Royalty Energy Junior Mining Precious Metals Project Generators Uncategorized

EMX Royalty Announces Third Quarter 2021 Results

Vancouver, British Columbia–(Newsfile Corp. – November 12, 2021) – EMX Royalty Corporation (NYSE American: EMX) (TSXV: EMX) (FSE: 6E9) (the “Company” or “EMX”) is pleased to report results for the quarter ended September 30, 2021 (“Q3-2021”). The Company’s filings for Q3-2021 are available on SEDAR at www.sedar.com, on the U.S. Securities and Exchange Commission’s website at www.sec.gov, and on EMX’s website at www.EMXroyalty.com. Financial results were prepared in accordance with International Financial Reporting Standards, as issued by the International Accounting Standards Board.

HIGHLIGHTS FOR Q3-2021

Significant Acquisitions

  • EMX closed the acquisition of a portfolio of royalty interests and deferred payments from SSR Mining Inc. and certain of its subsidiaries (“SSR Mining“) (see EMX news release dated October 21, 2021). The Portfolio consists of 16 geographically diverse base and precious metals royalties, with four royalty assets at advanced stages of project development, and also includes US $18 million in future cash payments. EMX has paid US $33 million in cash and issued 12,323,048 common shares of the Company valued at US $32.5 million to SSR Mining. SSR Mining now owns an approximate 12% undiluted equity interest in EMX. EMX will also make deferred and contingent payments to SSR Mining of up to US $34 million if certain project advancement milestones are achieved.
  • EMX completed the acquisition of an effective 0.418% NSR royalty on the Caserones Copper-Molybdenum Mine located in northern Chile for US$34.1 million in cash (see EMX news release dated September 3, 2021). Caserones is a significant porphyry copper-molybdenum mining operation in a top tier mining jurisdiction. The Caserones acquisition brings immediate cashflow to EMX’s portfolio. Through the quarter end, EMX has realized an initial payment of US $951,000 from the second quarter (i.e., April – June) royalty distributions.

Financial Update

Dollar amounts are in CDN unless otherwise noted.

  • As at September 30, 2021, EMX ended the quarter with a working capital balance of $13,889,000 including cash and cash equivalents of $46,735,000, investments, strategic investments, and receivables and loan receivables totaling $27,034,000, and debt of $54,134,000.
  • To facilitate the Caserones and SSR royalty acquisitions, as well as to supplement working capital, the Company has entered into three financing transactions including a US$44,000,000 credit facility with Sprott Private Resource Lending II (Collector), LP, a Vendor-take-back note of US$7.85 million with SSR Mining, and the closing of the first tranche of a private placement for gross proceeds of $20,913,000.
  • For the three months ended September 30, 2021, EMX had revenue and other income of $1,504,000. EMX also received or accrued from its effective royalty interest on the Caserones mine its first quarterly payment of approximately US$950,000.
  • Royalty generation costs for the three months ended September 30, 2021 totaled $3,882,000 including share-based compensation of $45,000, of which the Company recovered $1,792,000 from partners.
  • General and administrative expenses totaled $1,807,000. The increase from Q3-2020 is largely the result of increased due diligence costs related to the Caserones acquisition and other prospective royalty assets.
  • For the three months ended September 30, 2021, the Company had a net loss from operations of $10,866,000. In addition to operating items noted above, included in net loss from operations was $759,000 in depletion, depreciation, and direct royalty taxes, and $1,206,000 in share-based compensation. Other items affecting net loss in Q3-2021 include a gain from the Company’s investments in associated entities of $1,138,000 primarily related to its effective royalty interest in the Caserones mine, a fair value loss on investments of $3,731,000, and a foreign exchange gain of $1,301,000. The Company also recorded impairment charges of $4,178,000 including $4,022,000 related to its investment in Rawhide Acquisition Holding LLC (“RAH” or “Rawhide”). The foreign exchange gain was primarily related to the Company holding cash and net assets denominated in US.

Operational Update

EMX’s royalty and mineral property portfolio totals over 280 projects on five continents. The following summarizes the work conducted in Q3-2021, as well as subsequent events, by the Company and its partners.

  • In North America, EMX received provisional payments of approximately US$641,000 from the sale of 364 gold ounces produced at the Leeville royalty property in Nevada’s Northern Carlin Trend. Leeville’s Q3 performance ensures that 2021 will be a year of increased payments due to robust production contributions from Carlin East and Four Corners. On the royalty generation front, EMX continued to evaluate and add new gold and copper projects to the portfolio by staking open ground. Partner companies continued to build value in the portfolio with their summer field exploration programs. In particular, partner Ridgeline Minerals’ successes at Swift resulted in the Carlin-type gold project being optioned to Nevada Gold Mines. Ridgeline also reported additional encouraging drill results from the Selena sediment-hosted silver-gold project.

    EMX’s royalty and mineral asset portfolio in key mining districts of Ontario and Quebec, including the Red Lake camp, generated $75,000 in cash and fair value equity payments. EMX’s initiatives in Canada included staking prospective open ground, as well as expanding land positions at several existing properties.
  • In Serbia, Timok operator Zijin Mining Group Co. Ltd. (“Zijin”) received the final operating licenses and is in the trial production stage at the Upper Zone copper-gold project, which is covered by an EMX 0.5% NSR royalty. The Company filed an amended and restated Technical Report titled “NI 43-101 Technical Report – Timok Copper-Gold Project Royalty, Serbia” on SEDAR dated July 21, 2021 authored by Mineral Resource Management LLC.
  • In Fennoscandia, EMX executed an agreement for the sale of its Svärdsjö polymetallic project in Sweden to District Metals Corp. (TSX-V: DMX) for share equity, AAR payments, and retained royalty interests to EMX’s benefit. Subsequently EMX executed an option agreement for the sale of five battery metals projects in Sweden to Swedish Nickel Pty. Ltd. for share equity, AAR payments, retained royalty interests in the projects, work commitments and other consideration. As these six new deals were completed, partner companies continued to advance EMX’s royalty properties, which included further encouraging results from District’s drill program at the Tomtebo polymetallic project in Sweden’s Bergslagen mining district.
  • In Australia, the Company was granted the Copperhole Creek exploration license in the Georgetown Region of North Queensland. The Copperhole Creek project is available for partnership.

Corporate Update

EMX is monitoring developments regarding the ongoing coronavirus pandemic (“COVID-19”), with a focus on the jurisdictions in which the Company operates. EMX has implemented COVID-19 prevention, monitoring and response plans following the guidelines of international agencies and the governments and regulatory agencies of each country in which it operates. EMX’s priority is to safeguard the health and safety of its personnel and host communities, support government actions to slow the spread of COVID-19, and assess and mitigate the risks to business continuity. Although various levels of restrictions remain in place for some jurisdictions where the Company operates (e.g., travel restrictions, etc.), EMX’s field programs are up-and-running with in-country based staff.

Outlook

With the closing of the SSR and Caserones acquisitions, EMX continues to significantly strengthen its global portfolio of royalties. Gediktepe is one of several EMX royalty properties that are expected to commence production during late Q4, 2021 and early 2022. The others include the Timok development project in Serbia, where the Cukaru Peki high grade copper-gold deposit is being put into production by Zijin Mining Group Co. Ltd., and Balya North, a polymetallic Carbonate Replacement Deposit (“CRD”) in western Turkey being developed by Esan Eczacibaşi Endüstriyel Hammaddeler San. ve Tic. A.Ş., a private Turkish company.

EMX’s Leeville royalty in Nevada has delivered increased cash flows in recent months, with royalty production proceeds now being received from the Four Corners and Carlin East mining areas in addition to other areas on the royalty property. Together with cash flow already being received from its recently purchased Caserones copper-molybdenum royalty in Chile, EMX anticipates a significant increase in royalty revenue in 2022 from multiple assets that span four continents. See the EMX website (www.EMXroyalty.com) for further project and portfolio details.

The SSR royalty portfolio acquisition is an example of EMX’s corporate growth strategy, whereby the Company leveraged its in-region expertise to identify opportunities in jurisdictions where EMX already has a strategic presence, and hence a competitive advantage. This approach leads to value creation for the Company as well as synergies with existing EMX initiatives around the world. The Company is continuing with its assessments of royalty acquisition opportunities to continue growing the portfolio.

Meanwhile the Company’s royalty generation initiatives continued moving forward during Q3, which provided deal flow momentum moving into Q4. EMX partnered six projects in Fennoscandia for retained royalty interests, cash payments, and equity interests while continuing with field programs to add new projects to the royalty generation portfolio. In Australia, despite the challenges of COVID-19 lockdowns, the Company was successful in its efforts to add the Copperhole Creek project to the royalty generation portfolio. In the southwestern U.S., Regional Strategic Alliance (“RSA”) generative funds from South32 paid for identifying new copper properties for potential acquisitions. Elsewhere, multiple new precious-metals projects were staked by the Company in Idaho and Nevada which are now available for partnership. EMX is steadily building its generative portfolio in key mineral belts of the western U.S. and is now the third largest holder of mineral rights in Arizona and the second largest in Idaho. Fennoscandia, Australia, and the U.S. are stable exploration and mining jurisdictions, and EMX’s royalty generation assets provide prime opportunities for new partnerships.

EMX’s established partner companies continue to add value to the portfolio with encouraging drill results and other important advancements. In Fennoscandia, most notable were District’s drill success at Tomtebo (Norway) and further expansion of PGE-Ni-Cu mineralized zones at the Kaukua South project by Palladium One. In the western U.S. advancements included Ridgeline Minerals’ encouraging drill results from the Selena precious metals project on the Carlin Trend, and a joint venture agreement with Nevada Gold Mines for the Cortez Trend’s Swift gold project. EMX’s partners continued creating value on these assets, as well as others, at no cost to the Company. This trend of ongoing partner funded work expenditures is expected to carry forward, if not increase, going into Q4.

The Company will continue to strengthen its balance sheet through increased cashflows from royalties, deferred royalty payments, sale of investments, and other income. As part of this effort to strengthen working capital, in November 2021, the Company completed the first tranche of a $21.45 million private placement by the issuance of 6,337,347 units at $3.30 each for gross proceeds of $20.9 million. Increases to EMX’s treasury will allow it to continue project generation and royalty acquisition activities, thereby further building shareholder value (See Liquidity and Capital discussions below).

QUALIFIED PERSONS

Michael P. Sheehan, CPG, a Qualified Person as defined by NI 43-101 and employee of the Company, has reviewed, verified, and approved the above technical disclosure on North America. Eric P. Jensen, CPG, a Qualified Person as defined by NI 43-101 and employee of the Company, has reviewed, verified, and approved the above technical disclosure on Significant Acquisitions, Serbia, Fennoscandia, and Australia.

ABOUT EMX

EMX is a precious, base, and battery metals royalty company. EMX’s investors are provided with discovery, development, and commodity price optionality, while limiting exposure to risks inherent to operating companies. The Company’s common shares are listed on the NYSE American Exchange and the TSX Venture Exchange under the symbol EMX, as well as on the Frankfurt exchange under the symbol 6E9. See www.EMXroyalty.com for more information.

For further information contact:

David M. Cole
President and Chief Executive Officer
Phone: (303) 979-666
Dave@EMXroyalty.com

Scott Close
Director of Investor Relations
Phone: (303) 973-8585
SClose@EMXroyalty.com

Isabel Belger
Investor Relations (Europe)
Phone: +49 178 4909039
IBelger@EMXroyalty.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release may contain “forward looking statements” that reflect the Company’s current expectations and projections about its future results. These forward-looking statements may include statements regarding perceived merit of properties, exploration results and budgets, mineral reserves and resource estimates, work programs, capital expenditures, timelines, strategic plans, market prices for precious and base metal, or other statements that are not statements of fact. When used in this news release, words such as “estimate,” “intend,” “expect,” “anticipate,” “will”, “believe”, “potential” and similar expressions are intended to identify forward-looking statements, which, by their very nature, are not guarantees of the Company’s future operational or financial performance, and are subject to risks and uncertainties and other factors that could cause the Company’s actual results, performance, prospects or opportunities to differ materially from those expressed in, or implied by, these forward-looking statements. These risks, uncertainties and factors may include, but are not limited to: unavailability of financing, failure to identify commercially viable mineral reserves, fluctuations in the market valuation for commodities, difficulties in obtaining required approvals for the development of a mineral project, increased regulatory compliance costs, expectations of project funding by joint venture partners and other factors.

Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this news release or as of the date otherwise specifically indicated herein. Due to risks and uncertainties, including the risks and uncertainties identified in this news release, and other risk factors and forward-looking statements listed in the Company’s MD&A for the quarter ended September 30, 2021 (the “MD&A”), and the most recently filed Annual Information Form (“AIF”) for the year ended December 31, 2020, actual events may differ materially from current expectations. More information about the Company, including the MD&A, the AIF and financial statements of the Company, is available on SEDAR at www.sedar.com and on the SEC’s EDGAR website at www.sec.gov.